WL dims Sun’s shine … a bit A new year brings with it new hope but all indications are that 2016 is going to be a mixed… By Viveka RoychowdhuryUpdated: January 6, 2016 11:02 IST
Of laws and flaws Could New Jersey Superior Court’s decision this October be a wake up call for Indian companies with global ambitions By Viveka RoychowdhuryUpdated: December 19, 2015 20:51 IST
Sifting the trends into 2016 If the latest edition of the Antal Global Snapshot (AGS) on annual global hiring and firing trends is any indicator,… By Viveka RoychowdhuryUpdated: December 4, 2015 19:53 IST
Will new IP policy ensure Sabka Vikas? In our last issue, we highlighted Swati Spentose’s quiet rise to become a Rs 40-crore speciality API manufacturer By Viveka RoychowdhuryUpdated: November 20, 2015 10:53 IST
Finding the hidden gems Vishal Jajodia could sign up as a poster boy for Prime Minister Narendra Modi’s Make In India campaign By Viveka RoychowdhuryUpdated: November 5, 2015 11:19 IST
Balancing the scales Besides the balanced reasoning within the Delhi HC judgement, it is the SC’s intervention which could see this case go… By Viveka RoychowdhuryUpdated: October 13, 2015 12:11 IST
Mainstreaming AYUSH The last month saw a major milestone in the patent versus patient debate By Viveka RoychowdhuryUpdated: October 6, 2015 18:22 IST
Playing for high stakes According to the latest data from the India Brand Equity Foundation (IBEF), the Indian domestic pharma market ended FY15 with… By Viveka RoychowdhurySeptember 14, 2015 11:13 IST
Mylan’s One Quality Standard a long way off Some industry observers are surprised that ‘significant violations’ of this nature have not warranted an import alert or ban By Viveka RoychowdhuryAugust 24, 2015 12:34 IST
New strategies for growth After a decade of pain, there are some reassuring signs that the pharmaceutical industry may just be seeing the faint… By Viveka RoychowdhuryUpdated: August 20, 2015 12:40 IST
Digital India: A new game needs new rules With the launch of the Digital India campaign in early July, it is time to relook India Pharma Inc’s engagement… By Viveka RoychowdhuryUpdated: August 5, 2015 11:24 IST
Lee Pharma revives the CL debate With little known Lee Pharma filing India’s third compulsory licensing (CL), legal eagles and everyone interested or connected to pharmaceutical… By Viveka RoychowdhuryUpdated: July 20, 2015 17:59 IST
Divis Lab, Metropolis Healthcare among 174 BSE stocks to touch 52-week lows, 91 stocks hit 52-week highs
8 Photos Budget 2023: FM Nirmala Sitharaman matches her outfit with the Bahi Khaata Tab; See Photos 5 days agoFebruary 1, 2023
10 Photos In Pics: Amid rain, Beating the Retreat ceremony held at Vijay Chowk, marks the end of Republic Day celebrations 1 week agoJanuary 29, 2023
16 Photos Mughal Gardens now Amrit Udyan! Roses, tulips, other seasonal flowers beautify the gardens of Rashtrapati Bhavan – See Beautiful Photos 1 week agoJanuary 29, 2023
